GOA
LIVE

Serial Number

50011572

Owner

GOA Therapeutics Corporation

Attorney

Joyce Liou

Filing Date

Jul 24, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GOA Trademark

Serial Number: 50011572

GOA is a trademark filed by GOA Therapeutics Corporation on July 24, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

GOA Therapeutics Corporation (2 trademarks)

515 N. Flagler Dr
West Palm Beach, FL 33401

Entity Type: 03

Trademark Details

Filing Date

July 24, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for reducing blood ethanol concentration and acetaldehyde toxicity; pharmaceutical preparations for the treatment of alcohol intoxication, alcohol use disorder, nicotine addiction, substance use disorders, allergic diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, and Parkinson's disease; pharmaceutical preparations for smoking cessation; pharmaceutical preparations, namely, alcohol dehydrogenase and acetaldehyde scavenger formulations for reducing blood ethanol concentration and acetaldehyde toxicity

Providing medical information in the fields of alcohol intoxication, alcohol use disorder, nicotine addiction, substance use disorders, allergic diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, Parkinson's disease, blood ethanol concentration, acetaldehyde toxicity, and smoking cessation

Medical apparatus, namely, injection devices for administering pharmaceutical preparations; injection devices for use in administering pharmaceutical preparations for reducing blood ethanol concentration and acetaldehyde toxicity; injection devices for use in administering pharmaceutical preparations for the treatment of alcohol intoxication, alcohol use disorder, nicotine addiction, substance use disorders, allergic diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, and Parkinson's disease

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 24, 2026 MAFR
NEW APPLICATION ENTERED
Jul 24, 2026 NWAP